Implications of classifying birth control pills as cancer risk
The article discussed the classification of combined oral contraceptive pills containing estrogen and progestin within Group 1 of carcinogenic agents according to the International Agency for Research on Cancer. It clarified that this classification indicates there is scientific evidence that the agent can cause cancer under certain conditions, but it does not mean that everyone who uses it will develop the disease. The article confirmed that using oral contraceptives is associated with an increased risk of certain types of cancer, such as breast and cervical cancer, while it reduces the risk of ovarian and endometrial cancers by up to 50%. It explained that the relationship between contraceptive use and cancer is more complex, with factors like age and medical history influencing the risk, emphasizing the importance of medical consultation before stopping or starting use. The article also noted that sudden discontinuation may not prevent cancer or significantly alter the risks, and that such decisions should be based on a comprehensive assessment of individual health factors.
Notice: This Is an AI-Generated Summary
Comments (0)